Castle Creek Arbitrage’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

Castle Creek Arbitrage’s Portfolio ORIA Stock Details ORIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-530,000	Closed	-$5.42M	–	472
2023 Q1	$5.42M	Buy	+530,000	New	+$5.38M	0.6%	43

Castle Creek Arbitrage's ORIA Position: Q2 2023 in Review

Castle Creek Arbitrage sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q2 2023, closing a stake of 530,000 shares — an estimated $5.42M sold.

Castle Creek Arbitrage first reported a position in ORIA in Q1 2023 and held it in 1 quarter. The position peaked at $5.42M in Q1 2023. 0 funds tracked by Wall St. Rank hold ORIA as of Q2 2023.

Castle Creek Arbitrage reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q2 2023 after selling out during the quarter.
Castle Creek Arbitrage sold 530,000 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q2 2023, an estimated $5.42M.
Castle Creek Arbitrage first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q1 2023 and held it in 1 quarter.
Castle Creek Arbitrage's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $5.42M in Q1 2023.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q2 2023.

Based on Castle Creek Arbitrage's 13F filing for Q2 2023, filed 14 Aug 2023.